The Impact of Global Budgets on Pharmaceutical Spending and Utilization: Early Experience From the Alternative Quality Contract

被引：10

作者：

Afendulis, Christopher C. ^{[1
]}

Fendrick, A. Mark ^{[2
]}

Song, Zirui ^{[1
]}

Landon, Bruce E. ^{[1
]}

Safran, Dana Gelb ^{[3
]}

Mechanic, Robert E. ^{[4
]}

Chernew, Michael E. ^{[1
]}

机构：

[1] Harvard Univ, Sch Med, Boston, MA 02115 USA

[2] Univ Michigan Hlth Syst, Ann Arbor, MI USA

[3] Blue Cross & Blue Shield Massachusetts, Boston, MA USA

[4] Brandeis Univ, Boston, MA USA

来源：

INQUIRY-THE JOURNAL OF HEALTH CARE ORGANIZATION PROVISION AND FINANCING | 2014年 / 51卷

关键词：

pharmaceutical spending; global budgeting; bundled payment; health insurance; PAYMENT; CARE;

D O I：

10.1177/0046958014558716

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

In 2009, Blue Cross Blue Shield of Massachusetts implemented a global budget-based payment system, the Alternative Quality Contract (AQC), in which provider groups assumed accountability for spending. We investigate the impact of global budgets on the utilization of prescription drugs and related expenditures. Our analyses indicate no statistically significant evidence that the AQC reduced the use of drugs. Although the impact may change over time, early evidence suggests that it is premature to conclude that global budget systems may reduce access to medications.

引用

页码：1 / 7

页数：7

共 19 条

[1] The Impact of Medicare Part D on Hospitalization Rates [J].